Effect of Silymarin on Mouse Liver Damage, Production and Activity of Tumor Necrosis Factor

Yaoxue Xuebao

Volumn 31, Issue 8, 1996, Pages 577-580

  Zhang, J P ^a   Hu, Z L ^a   Feng, Z H ^b   Lin, W ^a   Yu, X B ^a   Qian, D H ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Beijing Four Rings Pharmaceutical F   (China)

Author keywords

Lipopolysaccharides; Liver damage; Silymarin; Tumor necrosis factor

Indexed keywords

LIPOPOLYSACCHARIDE; PROTECTIVE AGENT; SILYMARIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; TOXIC HEPATITIS;

ANIMALS; FEMALE; HEPATITIS, TOXIC; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED ICR; PROTECTIVE AGENTS; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030309759     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Muto Y, Nouri-Aria KT, Meager A et al. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet, 1988,2:72
2. Yoshioka K, Kakumu S, Arao M et al. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology, 1989,10:769
3. Liu P, Ohnishi H, Moriwaki H et al. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice. Gastroenterol Jpn, 1990, 25:339
4. Lui P, Zhou ZW, Dong XJ et al. The protective effects of anti-mouse TNF monoclonal antibody in experimental massive hepatic cell necrosis model. Chin Gastroenterol J, 1994,14:150
5. Fiebrich F, Koch H. Silymarin, an inhibilor of lipoxygenase. Silymarin, an inhibitor of prostaglandin synthetase. Experientia, 1979,35:1548-1550
6. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxicity assay for tumor necrosis factor. J Immunol Methods, 1984,68:167
7. Morrison DC, Ryan JC. Endotoxins and disease mechanism. Ann Rev Med, 1987,38:417